, which is indicated for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with high tumor burden.
Treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with high tumor burden
Let us work together to protect precious health